Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Pharm blk4- PD
Parkinson's Dz
| Question | Answer |
|---|---|
| What are the 4 cardinal signs of parkinson’s | 1.resting tremors, 2.bradykinesia, 3.lead-pipe rigidity, 4.poor balance (you need 2 to be dxed) |
| What happens to what part of the brain in parkinson’s (how much, + compared to normal) | 80% Loss of DA neurons in substantia nigra (normal is 5% loss per decade) |
| What are 3 hypothesis on how DA neurons are destroyed | 1.mitochondia dysfunction, 2.glutamate toxicity, 3.oxidative stress |
| What is the life expectancy once dxed with parkinson’s | 3-5 yrs |
| What is one neuro-muscular feature which is intact in parkinson’s (think) | Reflexes |
| What drugs often lead to PD-like Sxs | Antipsychotics (anti-DA) |
| What drug have we learn can lead to PD Sxs (1~2) | Meperidine (MPPP) contaminated with MPTP |
| How does MPTP lead to PD-like Sxs | MPTP is taken by DA neurons, and it is converted to MAOB, which causes free radical stress on the mitochondrial (and neuron death) |
| Describe the basal ganglia system: (precise) (start with SN) | Substansia Nigra has DA neuron that project on the Striatum, when activated those prevent the Globus Pallidus from inhibiting the thalamus (thus preventing motion, and resting inhibition) |
| Where in the basal ganglia system is DA missing | STRIATUM not substansia nigra (SN is missing neurons) |
| Describe the dopamine receptors | 1.D1 is excitatory (increase cAMP, and Ca), 2.D2 is inhibitory (decrease cAMP, and increase K) |
| What enzyme is central to the oxidative stress theory of PD | MAO (monoamine oxidase) |
| what is the gold standard drug for PD (describe it quickly) | L-Dopa, precursor for DA |
| what is the main difference btw L-Dopa and DA: | L-Dopa crosses the BBB |
| How come L-Dopa is so selective | It is only decarboxlated to DA in the nigrostriatal neurons |
| Describe the efficacy of L-Dopa on patients: | 1/3 well, 1/3 moderate, 1/3 poor (75% works) |
| what are the 3 MOA, disadvantages of L-Dopa | 1.decrease efficacy over time (only works for few years), 2.doesn’t stop progression of disease, 3.doesn’t work on very advanced cases (can’t be decarboxylated if no neurons are left) |
| Mention the pharmaco of L-Dopa: (4: absorption, peak , T1/2, brain penetrance) | 1.amino acids in diet decrease gut and BBB absorption, 2.peak: 1-2 hrs, 3. Short T1/2 (2hrs), thus must be given multiple times a day, 4.only 2% enters brain |
| What are the sides effect of L-Dopa: | Peripheral DA:1.GI, 2. tachycardia, 3.hypotension, Central DA:4.AIMs (jerky movements), 5.Psychotomimetic (txed w/ antipsychotics) |
| Discuss wearing off and on/off problems with L-Dopa: | As tolerance progresses: you get wearing off (drug stops working before next drug schedule), or on/off (drug stops working in middle of tx) |
| What is often given with L-Dopa to improve brain penetrance (what is it) | Carbidopa (DOPA decarboxylase inhib, prevents the decarboxylation outside nigrostriatal neurons – it does not cross the BBB) |
| Carbidopa reduces which AE (3) | 1.GI (nausea/vomiting), 2.tachycardia, 3.hypotension |
| What is carbidopa + L-dopa called: | Sinemet |
| what awkward regimen used to be recommend to PD patients (why And why not anymore(2) | Drug holiday to improve response. It causes more problem: depression, immobility Cx |
| Discuss drug interaction of L-Dopa: (2) | Vit B6 (increase peripheral metabolism), MAOA inhib (can lead to hypertensive crisis) |
| Who should not get L-Dopa: (5) | 1.psychosis, 2.glaucoma, 3.cardiac disease (ok if carbidopa), 4.peptic ulcers, 5.skin tumors Hx (melanoma) |
| what is often added to sinemet (why, what is the new mix called) | Entacapone (COMT inhib). COMT transforms L-Dopa in 3OMD, which competes with L-Dopa for BBB penetration. The new mix is Stalevo. |
| what are the AE of stalevo (5) | Mostly due to increase L-Dopa: 1.orange urine, 2.nausea, hypotension, 3.dyskinesia, 4.hallucinations, 5.sleep problems |
| what is the monotherapy agent of choice for PD | DA agonists |
| List the DA agonist (5 in 3 categories) (include receptors targeted) | Ergot: 1.bromocriptine (D2), 2.pergolide (D1-D2), Non-ergo: 3.pramipexole (D3), 4.ropinarole (D2), Rescue :Apomorphine |
| What are 2 MOA advantages of DA agonist over L-Dopa | 1.doesn’t require conversion (which can lead to free radicals), 2.doesn’t need working neurons |
| What are the 2 ways DA agonist are introduced: | 1.bythemselves, 2.with Sinemet as it starts losing its effect |
| Which DA family are preferred | Non-ergot |
| What is 1 pro and 1 con of pergolide: | Pro: increase time on (in on/off problem), Con: valvular disease |
| what is 2 pro and 1 con of pramipexole: | Pro: increase time on (in on/off problem) & antioxidant, Con: kidney problems |
| What is 1 pro and 1 con of ropinirole | Pro: increase time on (in on/off problem), Con: CYP1A2 |
| what was apomorphine 1st used for | Induce vomiting |
| What is apomorphine used for | Someone stuck in off state |
| How is apomorphine given: | Subcu |
| Main AE of apomorphine: | Vomiting (trimethobenzamide must be given 3 days before, and till one month after) |
| AE of DA agonist: | Same as L-dopa go look + perivascular disease if from ergot family |
| Other than DA agonist and L-dopa, what else is commonly used in PD: | 1.MAO inhib (selegiline), 2.amantadine, 3.muscarinic receptor antagonist (benztropine mesylate) |
| What are the 2 MOA of MAO inhib | 1.blocking MAO-B increase DA (MAO-A is for NE), 2.blocking MAO decrease oxidative stress) |
| Selegiline is what type of MAO inhib: | Irreversible (thus long T1/2) |
| Selegiline can also be used to prevent: | MPTP toxicity |
| What should not be used with Selegiline: | MAO, SSRIs |
| How does amantadine work: | unknown |
| what is the main advantage of amantadine: | Decrease dyskinesia |
| AE of amantadine: | Like L-Dopa + livedo reticularis, peripheral edema |
| Who should not get amantadine: (2) | Hx of seizure, Hx of heart failure |
| How is amantadine given: | With sinemet |
| MOA of benztropine: | Reduce ACh to balance ACh:DA ratio |
| AE of benztropine: | 1.abuse, 2.hallucination, anti-cholinergic: 3.tachycardia, tachypnea |
| Name 4 meds and 4 procedure that can/could be use for PD: | Meds: 1.beta-block, 2.NE, 3.benzos, 4.antihistamines, Procedures: 1.thalamomotomy, 2pallidotomy, 3.thalamic or palladic deep brain stimulation, 4.fetal allograft |
Created by:
mcafej02
Popular Science sets